“It ain't over … till it's over!” Risk‐mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID‐19 pandemic-Reference-Cited by-同舟云学术

“It ain't over … till it's over!” Risk‐mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID‐19 pandemic

Published:2020-06-29 Issue:7 Volume:35 Page:1117-1123
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Holtmann Gerald¹^ORCID,Quigley Eamonn M²,Shah Ayesha¹,Camilleri Michael³,Tan Victoria PY⁴,Gwee Kok Ann⁵,Sugano Kentaro⁶,Sollano Jose D⁷,Fock Kwong M⁸,Ghoshal Uday C⁹^ORCID,Chen Minhu¹⁰,Dignass Axel¹¹,Cohen Henry¹²

Affiliation:

1. Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Faculty of MedicineUniversity of Queensland Brisbane Queensland Australia

2. Lynda K and David M Underwood Center for Digestive Disorders, Houston MethodistWeill Cornell Medical College New York New York USA

3. Division of Gastroenterology & HepatologyMayo Clinic Rochester Minnesota USA

4. Faculty of MedicineUniversity of Hongkong Hongkong

5. Yong Loo Lin School of MedicineNational University of Singapore Singapore

6. Department of Medicine, Division of GastroenterologyJichi Medical University Shimotsuke Japan

7. Department of GastroenterologyUniversity of Santo Tomas Manila Philippines

8. Faculty of MedicineNational University of Singapore Singapore

9. Department of GastroenterologySanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow India

10. Department of Gastroenterology and HepatologyThe First Affiliated Hospital Sun Yat‐sen University Guangzhou China

11. Department of MedicineAgaplesion Markus Hospital Frankfurt Germany

12. Clínica de GastroenterologíaFaculta de Medicina Montevideo Uruguay

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15133

Reference24 articles.

1. Pandemics: Risks, Impacts, and Mitigation

2. Covid‐19 and the digestive system

3. COVID‐19 and paediatric inflammatory bowel diseases: global experience and provisional guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN;Turner D;J. Pediatr. Gastroenterol. Nutr.,2020

4. Evolving therapeutic goals in ulcerative colitis: towards disease clearance

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer;Middle East Journal of Digestive Diseases;2024-01-31

2. Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics;Gastrointestinal Endoscopy;2022-11

3. COVID-19 Risk Management and Stakeholder Action Strategies: Conceptual Frameworks for Community Resilience in the Context of Indonesia;International Journal of Environmental Research and Public Health;2022-07-22

4. The impact of COVID‐19 on the delivery of care by Australian primary health care nurses;Health & Social Care in the Community;2022-01-10

5. Impact of the COVID-19 pandemic on the experiences of hepatology nurses in Canada;Gastrointestinal Nursing;2021-07-01